Company:  REPLIGEN CORP (RGEN)
Form Type:  8-K
Filing Date:  5/25/2012 
CIK:  0000730272 
Address:  41 SEYON STREET
BUILDING 1, SUITE 100
 
City, State, Zip:  WALTHAM, Massachusetts 02453 
Telephone:  (781) 449-9560 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$15.66  
Change: 
-0.18 (-1.14%)  
Trade Time: 
04:00 PM EST  
Market Cap: 
$501.75M
Description of Business
The following discussion of our business contains forward-looking statements that involve risks and uncertainties. When used in this report, the words �intend,� �anticipate,� �believe,� �estimate,� �plan� and �expect� and similar expressions as they relate to us are included to identify forward-looking statements. Our actual results could differ materially from those anticipated in these forward-looking statements and are a result of certain factors, including those set forth under �Risk Factors� and elsewhere in this Annual Report on Form 10-K. Overview Repligen Corporation (�Repligen,� the �Company� or �we�) is a life sciences company that develops, manufactures and markets high-value, consumable bioprocessing products for life sciences and biopharmaceutical companies worldwide. We are a world-leading manufacturer of both native and recombinant forms of Protein A, critical reagents used in biomanufacturing to purify monoclonal antibodies, a type of biologic drug.
Register for EDGAR Pro and access this filing in:     
  FORM 8-K
    SECTION 5 CORPORATE GOVERNANCE
      Item 5.02. Departure of Directors or Certain Officers; ...
      Item 5.03. Amendments to Articles of Incorporation or ...
      Item 5.07. Submission of Matters to a Vote of Security Holders.
    SECTION 8 OTHER EVENTS
      Item 8.01. Other Events.
    SECTION 9 FINANCIAL STATEMENTS AND EXHIBITS
      Item 9.01. Financial Statements and Exhibits.
    SIGNATURES
    EXHIBIT INDEX
  EXHIBIT 3.1
  EXHIBIT 10.1
BROKERAGE PARTNERS